Novartis Raises FY23 Outlook Due To Strong Momentum, Now Expects Core Operating Income To Grow Mid To High Teens (From Low Double Digit To Mid-Teens); Reaffirms Net Sales To Grow High Single Digit
Portfolio Pulse from Benzinga Newsdesk
Novartis has raised its FY23 outlook due to strong momentum. The company now expects its core operating income to grow mid to high teens, up from the previous guidance of low double digit to mid-teens growth. The forecast for net sales growth remains unchanged at high single digit.
October 24, 2023 | 7:24 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Novartis has raised its FY23 outlook, which could lead to increased investor confidence and potentially a rise in the company's stock price.
Novartis' raised FY23 outlook indicates strong performance and growth, which is likely to be viewed positively by investors. This could lead to increased demand for the company's stock, potentially driving up its price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100